Sponsor:
C4 Therapeutics, Inc.
Code:
NCT07284758
Conditions
Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cemsidomide
Dexamethasone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-24. This information was provided to ClinicalTrials.gov by C4 Therapeutics, Inc. on 2026-01-15.